Good afternoon and welcome to Markets Desk.
Aluminum is back in focus today, and Alcoa is sitting at the center of it. Conflict in the Middle East has pulled roughly nine percent of global aluminum supply off the market, sending prices sharply higher. Analysts now expect that tightness to persist for another one to two years, giving Alcoa a sustained earnings tailwind that the market is only beginning to price in.
Shifting to pharmaceuticals, the GLP-one space continues to expand its addressable market. A new study suggests these weight-loss medications may also be effective in reducing chronic inflammation, a finding that could dramatically broaden the therapeutic case for the entire drug class. That said, enthusiasm for individual names like Viking Therapeutics has cooled considerably, and analysts are urging caution before chasing the sector's more speculative players.
And over in Tokyo, the Nikkei two twenty five snapped a three-session winning streak Tuesday, falling well off its opening gains despite broadly constructive signals out of European markets. Wall Street offered no overnight cues to anchor sentiment, leaving Japanese traders without a directional anchor. The reversal is a reminder that regional momentum can fade quickly when global catalysts are thin on the ground.
That's the tape. Markets Desk, signing off the floor.
